BioCertica logo — The first African-based Genetic company to introduce cutting...

BioCertica

The first African-based Genetic company to introduce cutting-edge methodology to generate your DNA test results.

Founded 2019 United States Wilmington, United States 13 employees Seed Total: $2.30M Analytics, Biotechnology

General Information

Company Name BioCertica
Founded Year 2019
Location United States Wilmington, United States
Founders / Decision Makers
Team member Team member
Employees 13
Industries Analytics, Biotechnology
Funding Stage Seed
Business Model B2C, E Commerce, D2C
Revenue Model Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with BioCertica. To contact BioCertica, visit biocertica.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioCertica compare?

A PDF of BioCertica and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioCertica soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioCertica

BioCertica, founded in 2019, is a pioneering biotechnology company that has positioned itself as Africa's first digital biobank. Headquartered in the United States, it merges advanced genetic testing with encryption technology to deliver secure, actionable insights from DNA tests. With its slogan, "The first African-based Genetic company to introduce cutting-edge methodology to generate your DNA test results," BioCertica emphasizes its innovative approach.

Operating in the Analytics and Biotechnology industries, BioCertica offers a suite of DNA tests designed to empower individuals to make informed decisions about their health and wellness. A key differentiator lies in its commitment to privacy, ensuring that users maintain control over their genetic information without third-party sales.

The company recently received a $50.00K Grant investment in September 2023 from Investing In Innovation Africa. This investment underscores confidence in BioCertica's potential to reshape the genetic testing landscape in Africa.

Business keywords: Genetic Testing, Digital Biobank, DNA Sequencing, Secure Bio-Identity, Genetic Information Privacy, Encryption Technology, Health Empowerment, Actionable Genetic Insights, DNA Processing Machines, Advanced Methodology, Central Analytics, Biometric Security

Services & Products

Comprehensive DNA Testing
Personalized Health Recommendations
Genetic Risk and Disease Analysis
Biometric Data Integration
AI-Driven Health Insights

Target Customers

Health-Conscious Individuals Fitness Enthusiasts Healthcare Practitioners Individuals Seeking Preventive Healthcare

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $50.00K 1
Investing In Innovation Africa
01 Sep 2023
Seed $1.60M -
01 Apr 2022
Seed $650.00K -
01 Jan 2021

BioCertica Alternatives & Competitors

BioCertica vs
InsideTracker
InsideTracker United States

Live healthier longer with a personalized Action Plan, combining data from blood biomarkers, DNA, an...

Series B
66 employees
Analytics, Biotechnology

FAQ About BioCertica

The first African-based Genetic company to introduce cutting-edge methodology to generate your DNA test results.
BioCertica was founded in 2019.
BioCertica is headquartered in Wilmington, United States.
BioCertica operates in Analytics and Biotechnology. Its work centres on Genetic Testing, Digital Biobank, DNA Sequencing and Secure Bio-Identity. Its customers include Health-Conscious Individuals, Fitness Enthusiasts and Healthcare Practitioners.
BioCertica has a B2C, E Commerce and D2C business model. Its revenue comes from Product Sales and Service Fee.
BioCertica has approximately 13 employees.
BioCertica has completed 3 funding rounds, raising a total of $2.30M. The latest funding stage is Seed.
BioCertica offers: Comprehensive DNA Testing, Personalized Health Recommendations, Genetic Risk and Disease Analysis, Biometric Data Integration, AI-Driven Health Insights.
Top alternatives and competitors to BioCertica include InsideTracker. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioCertica and InsideTracker are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioCertica, https://bouncewatch.com/company/biocertica, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes